DGKI and cancer: Pathways related to ECM receptor interactions, focal adhesion, calcium signaling, TGF-beta signaling, MAPK signaling, Hedgehog signaling, cell adhesion molecules (CAMs), adherens junctions, and cancer were differentially enriched with the DGKI high expression phenotype (Figure 5).